EVALUATING PAEDIATRIC ANTIBIOTIC USE: PREVALENCE OF DRUG-DRUG INTERACTIONS AND THE NEED FOR ANTIMICROBIAL STEWARDSHIP

Main Article Content

Dr Gaurav Mishra
Dr Shweta Mishra

Keywords

Antibiotic resistance, Paediatric infections, Drug-drug interactions, Antimicrobial stewardship, Ceftriaxone, Antibiotic prescribing patterns

Abstract

Background: Antimicrobial resistance (AMR) is a growing global health crisis, with paediatric populations particularly vulnerable to inappropriate antibiotic use. This study aimed to evaluate antibiotic prescribing patterns, the prevalence of drug-drug interactions (DDIs), and the extent of microbiological testing among paediatric inpatients.


Methods: A prospective observational study was conducted over six months in the paediatric department of Varun Arjun Medical College & Rohilkhand Hospital. A total of 150 paediatric inpatients receiving antibiotic therapy were included. Data on demographics, infection type, prescribed antibiotics, dosage forms, DDIs, and antibiotic sensitivity testing were collected and analyzed. Descriptive statistics were used to assess prescribing patterns and interactions.


Results: Among the 150 enrolled patients, males (56.00%) were more predominant than females (44.00%). The majority (55.33%) were aged 1-11 years. Respiratory tract infections (RTIs) (33.00%) were the most common indication for antibiotic therapy, followed by gastrointestinal infections (24.66%). Ceftriaxone (24.66%) was the most frequently prescribed antibiotic. Injectable formulations (91.30%) were preferred over oral formulations. A total of 26.70% subjects were found to have drug-drug interactions (DDIs). Only 6.70% of patients underwent antibiotic sensitivity testing, highlighting a gap in microbiological confirmation before antibiotic initiation.


Discussion: The findings emphasize the overuse of broad-spectrum antibiotics and the low rate of microbiological testing in paediatric patients, raising concerns about AMR. The high prevalence of DDIs underscores the need for enhanced pharmacovigilance and integration of electronic prescribing systems to monitor interactions. The lack of institutional guidelines for paediatric antibiotic use contributes to inconsistent prescribing patterns, necessitating implementing antimicrobial stewardship programs (ASPs) to optimize antibiotic selection and minimize resistance risks.


Conclusion: This study underscores the need for standardized institutional guidelines and antimicrobial stewardship programs to ensure judicious antibiotic use in paediatric inpatients. Enhancing microbiological testing, implementing electronic prescribing systems, and promoting transition from injectable to oral therapy can significantly improve antibiotic prescribing practices and reduce AMR risk.

Abstract 54 | pdf Downloads 28

References

1. World Health Organization. Global action plan on antimicrobial resistance. WHO; 2015.
2. O’Neill J. Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance; 2016.
3. Ventola CL. The antibiotic resistance crisis: Part 1: Causes and threats. P T. 2015;40(4):277-83.
4. Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399(10325):629-55.
5. Kaur R, Kaur H. Antibiotic overuse in children and its consequences: A review. J Clin Diagn Res. 2017;11(6):SE04-SE06.
6. Sader HS, Mendes RE, Streit JM, Carvalhaes CG, Castanheira M. Antimicrobial susceptibility of Gram-negative bacteria isolated from pediatric patients globally. J Pediatric Infect Dis Soc. 2020;9(4):444-51.
7. Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen JA, Klugman K, Davies S. Access to effective antimicrobials: A worldwide challenge. Lancet. 2016;387(10014):168-75.
8. Hersh AL, Jackson MA, Hicks LA. Principles of judicious antibiotic prescribing for upper respiratory tract infections in Paediatrics. Paediatrics. 2013;132(6):1146-54.
9. Patel SJ, Saiman L. Antibiotic stewardship programs in pediatric settings: Need for action. J Pediatric Infect Dis Soc. 2019;8(4):340-7.
10. Choudhury S, Ghosh S. Drug-drug interactions in hospitalized pediatric patients: A systematic review. Int J Clin Pharm. 2021;43(5):1172-85.
11. Barlam TF, Cosgrove SE, Abbo LM, MacDougall C, Schuetz AN, Septimus EJ, Srinivasan A, Dellit TH, Falck-Ytter YT, Fishman NO. Implementing an antibiotic stewardship program: Guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2016;62(10):e51-77.
12. Nathwani D, Tillotson G. Antimicrobial resistance and infection control strategies in the developing world: Lessons learnt and innovations required. J Infect Public Health. 2019;12(1):1-2.
13. Van den Anker JN, Allegaert K. Rational use of antibiotics in neonates and children: A worldwide challenge. J Pediatr Pharmacol Ther. 2021;26(3):188-94.
14. Versporten A, Bielicki J, Drapier N, Sharland M, Goossens H. The global pediatric antibiotic prescribing pattern: A systematic review. Lancet Infect Dis. 2016;16(5):573-81.
15. Hsia Y, Sharland M, Jackson C, Wong IC. Antibiotic prescribing in pediatric inpatients: A systematic review and meta-analysis. J Antimicrob Chemother. 2019;74(3):777-91.
16. McMullan BJ, Andresen D, Blyth CC, Avent ML, Bowen AC, Britton PN, et al. Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: A systematic review. Lancet Infect Dis. 2016;16(8):e139-52.
17. Smith MJ, Gerber JS, Hersh AL. Inpatient antimicrobial stewardship in Paediatrics: A systematic review. J Pediatric Infect Dis Soc. 2015;4(4):e127-35.